半胱氨酰白三烯受体2拮抗剂筛选方法的建立及化合物初筛

Q256%Q421; 目的:建立半胱氨酰白三烯受体2(CysLT_2受体)拮抗剂筛选的细胞模型及方法,初筛系列合成化合物.方法:选用高表达CysLT_2受体的大鼠C6胶质瘤细胞,激动剂LTD_4攻击后检测细胞内钙浓度变化,作为CysLT_2受体拮抗剂的筛选方法,初步筛选有拮抗剂活性的化合物.采用CysLT1/CysLT_2受体非选择性拮抗剂Bay u9773和CysLT_2受体选择性拮抗剂AP-100984作为参照.结果:RT-PCR鉴定表明C6细胞高表达CysLT_2受体.LTD_4 1 μmol/L能显著升高C6细胞内钙,其作用约为阳性对照ATP的37 5%.CysLT_2受体拮抗剂抑制L...

Full description

Saved in:
Bibliographic Details
Published in浙江大学学报(医学版) Vol. 38; no. 6; pp. 598 - 604
Main Authors 蔡蓓蕾, 黄雪琴, 董晓武, 方三华, 卢韵碧, 张纬萍, 胡永洲, 魏尔清
Format Journal Article
LanguageChinese
Published 浙江大学医学院药理学系,浙江,杭州,310058%浙江大学药学院药物研究所,浙江,杭州,310058 2009
Subjects
Online AccessGet full text
ISSN1008-9292
DOI10.3785/j.issn.1008-9292.2009.06.008

Cover

Abstract Q256%Q421; 目的:建立半胱氨酰白三烯受体2(CysLT_2受体)拮抗剂筛选的细胞模型及方法,初筛系列合成化合物.方法:选用高表达CysLT_2受体的大鼠C6胶质瘤细胞,激动剂LTD_4攻击后检测细胞内钙浓度变化,作为CysLT_2受体拮抗剂的筛选方法,初步筛选有拮抗剂活性的化合物.采用CysLT1/CysLT_2受体非选择性拮抗剂Bay u9773和CysLT_2受体选择性拮抗剂AP-100984作为参照.结果:RT-PCR鉴定表明C6细胞高表达CysLT_2受体.LTD_4 1 μmol/L能显著升高C6细胞内钙,其作用约为阳性对照ATP的37 5%.CysLT_2受体拮抗剂抑制LTD_4诱导的C6细胞内钙升高,CysLT_1受体选择性拮抗剂无抑制作用.化合物中DXW-1、2、13、23、29、30能抑制LTD_4诱导的细胞内钙升高.结论:LTD_4诱导的C6细胞的钙信号变化可作为CysLT_2受体拮抗剂的筛选方法;化合物DXW-1、2、13、23、29、30具有CysLT_2受体拮抗活性.
AbstractList Q256%Q421; 目的:建立半胱氨酰白三烯受体2(CysLT_2受体)拮抗剂筛选的细胞模型及方法,初筛系列合成化合物.方法:选用高表达CysLT_2受体的大鼠C6胶质瘤细胞,激动剂LTD_4攻击后检测细胞内钙浓度变化,作为CysLT_2受体拮抗剂的筛选方法,初步筛选有拮抗剂活性的化合物.采用CysLT1/CysLT_2受体非选择性拮抗剂Bay u9773和CysLT_2受体选择性拮抗剂AP-100984作为参照.结果:RT-PCR鉴定表明C6细胞高表达CysLT_2受体.LTD_4 1 μmol/L能显著升高C6细胞内钙,其作用约为阳性对照ATP的37 5%.CysLT_2受体拮抗剂抑制LTD_4诱导的C6细胞内钙升高,CysLT_1受体选择性拮抗剂无抑制作用.化合物中DXW-1、2、13、23、29、30能抑制LTD_4诱导的细胞内钙升高.结论:LTD_4诱导的C6细胞的钙信号变化可作为CysLT_2受体拮抗剂的筛选方法;化合物DXW-1、2、13、23、29、30具有CysLT_2受体拮抗活性.
Abstract_FL Objective: To establish a method for screening cysteinyl leukotriene receptor 2 (CysLT_2) antagonists and to preliminarily screen a series of synthetic compounds. Methods: Rat glioma cell line (C6 cells) highly expressing CysLT_2 receptor was used.Intracellular calcium concentration was measured after stimulation with the agonist LTD_4,which was used to screen compounds with antagonist activity for CysLT_2 receptor.Bay u9773,a CysLT_1/CysLT_2 receptor non-selective antagonist,and AP-100984,a CysLT_2 receptor antagonist,were used as control. Results: PT-PCR showed a higher expression of CysLT_2 receptor in C6 cells.LTD_4 at 1 μmol/L significantly increased intracellular calcium in C6 cells;the maximal effect was about 37.5% of ATP,a positive stimulus.LTD_4-induced increase of intracellular calcium was blocked by CysLT_2 receptor antagonists,but not by CysLT_1 receptor antagonists.Among the synthetic compounds,DXW-1,2,13,23,29 and 30 inhibited LTD_4-induced increase of intracellular calcium. Conclusions: LTD_4-induced change in intracellular calcium in C6 cells can be used as a screening method for CysLT_2 receptor antagonists.The compounds,DXW-1,2,13,23,29 and 30,possess antagonist activity for CysLT_2 receptor.
Author 魏尔清
张纬萍
蔡蓓蕾
黄雪琴
方三华
胡永洲
董晓武
卢韵碧
AuthorAffiliation 浙江大学医学院药理学系,浙江,杭州,310058%浙江大学药学院药物研究所,浙江,杭州,310058
AuthorAffiliation_xml – name: 浙江大学医学院药理学系,浙江,杭州,310058%浙江大学药学院药物研究所,浙江,杭州,310058
Author_FL HUANG Xue-qin
LU Yun-bi
ZHANG Wei-ping
CAI Bei-lei
HU Yong-zhou
DONG Xiao-wu
FANG San-hua
WEI Er-qing
Author_FL_xml – sequence: 1
  fullname: CAI Bei-lei
– sequence: 2
  fullname: HUANG Xue-qin
– sequence: 3
  fullname: DONG Xiao-wu
– sequence: 4
  fullname: FANG San-hua
– sequence: 5
  fullname: LU Yun-bi
– sequence: 6
  fullname: ZHANG Wei-ping
– sequence: 7
  fullname: HU Yong-zhou
– sequence: 8
  fullname: WEI Er-qing
Author_xml – sequence: 1
  fullname: 蔡蓓蕾
– sequence: 2
  fullname: 黄雪琴
– sequence: 3
  fullname: 董晓武
– sequence: 4
  fullname: 方三华
– sequence: 5
  fullname: 卢韵碧
– sequence: 6
  fullname: 张纬萍
– sequence: 7
  fullname: 胡永洲
– sequence: 8
  fullname: 魏尔清
BookMark eNo9UMtKw0AA3EMFa-1feJOsm93NJnuU4gsCXnoP2WQjDZKCQYyexCo0qVJBbFHxroha8eKD_k03sX9hRJE5DAzDDDNzoBK1IwnAgo4gMS1jKYStOI6gjpClccwxxAhxiBgshQqo_uuzoB7HLYEMnZglUBXY6iz76rzko7vpyai4Gk_e0qLzrPrDyfgC572nPBuq9Kh4vJkepvngPX-9LK6P1edH8dBT_UydDtR5t0jvVfe29MyDmcDdjmX9j2ugubrSbKxr9ubaRmPZ1jxGLE1SgblOTc8gHFNkMCqoJ6n0AtcnjHmSBIwJYgpMfN_ilBDLxIFhuNLi0meU1MDib-yeGwVutOWE7d2dqCx0DkI_SYSzn4ifAxArd5NvzBBu8A
ClassificationCodes Q256%Q421
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3785/j.issn.1008-9292.2009.06.008
DatabaseName Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitle_FL Method for screening cysteinyl leukotriene receptor 2 antagonists and preliminary screening of compounds
EndPage 604
ExternalDocumentID zjdxxb_yxb200906008
GrantInformation_xml – fundername: 国家自然科学基金; 浙江省科技计划重点项目
  funderid: (30772561); (2005C23041)
GroupedDBID 2B.
4A8
92I
93N
ALMA_UNASSIGNED_HOLDINGS
PSX
RPM
TCJ
ID FETCH-LOGICAL-c638-e4b29147c539240564b4ce4ecfad366ce3f66b37b23dd89433872f55ae89ed643
ISSN 1008-9292
IngestDate Thu May 29 04:07:20 EDT 2025
IsPeerReviewed false
IsScholarly true
Issue 6
Keywords 半胱氨酰白三烯
半胱氨酸/遗传
白三烯/遗传
CysLT_2 receptor
C6细胞
Calcium
Cysteinyl leukotriene
钙离子
Receptors
受体
C6 cells
Cysteine/genet
receptor antagonist
leukotriene/genet
CysLT_2受体
受体拮抗剂
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c638-e4b29147c539240564b4ce4ecfad366ce3f66b37b23dd89433872f55ae89ed643
PageCount 7
ParticipantIDs wanfang_journals_zjdxxb_yxb200906008
PublicationCentury 2000
PublicationDate 2009
PublicationDateYYYYMMDD 2009-01-01
PublicationDate_xml – year: 2009
  text: 2009
PublicationDecade 2000
PublicationTitle 浙江大学学报(医学版)
PublicationTitle_FL JOURNAL OF ZHEJIANG UNIVERSITY(MEDICAL SCIENCES)
PublicationYear 2009
Publisher 浙江大学医学院药理学系,浙江,杭州,310058%浙江大学药学院药物研究所,浙江,杭州,310058
Publisher_xml – name: 浙江大学医学院药理学系,浙江,杭州,310058%浙江大学药学院药物研究所,浙江,杭州,310058
SSID ssib051373730
ssib002263662
ssib009993744
ssib056826211
ssib058720545
ssib006576290
ssib006704889
ssj0002507821
ssib006562844
ssib002039758
ssib008143987
ssib008679799
ssib001051301
ssib001104240
Score 1.7762972
Snippet Q256%Q421;...
SourceID wanfang
SourceType Aggregation Database
StartPage 598
Title 半胱氨酰白三烯受体2拮抗剂筛选方法的建立及化合物初筛
URI https://d.wanfangdata.com.cn/periodical/zjdxxb-yxb200906008
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LahRBcAgRghfxiW9ySB837jy6p_vYsztLEOMpQm5hXqt4WEETiDmIGIVsokQQE1Q8eFNEjXjxQf4ms2v-wqqacbY3BElkl6V2pl5d1XRXddf0WNZElEZRVI_rNd-GIdBLXV6LeYxFAG7ktGXqRQIfFJ6-LqZueFdn-ezI6DujamlhPp5MlvZ9ruR_vArXwK_4lOwhPFsxhQsAg3_hFzwMvwfyMQs5k00mNQslky4LbBYKFtSZlixUTHKEQ58pxYImCz0WAJrCK4CsW0TeYsqnW00GQRbSy4DpkABN9zjSSAfJNCAFxLpOjARTII-AwGWKkzDNpIdUQcACTVQB8iyEoa4ANJAQAAV8JCmkmFZ0SzLVrGSZsTNJ4dgYBGymqAHaY5qUBHwtDID016BSiwUNkkJyg8DAIbl4q8CpFkXQngoY2wS4-EUA2hQOUBTywqYqNIqmpkJ7Am-Ii820S4ZSxEUUogcolQkr7xQ-DYfWYwbj_UGtsLepCkm0Qz2lSc4nbaUYMgd4Eaicxj5SiovgG0BG7wI5VtLi1g2XzOEHU6yS_k_Fyt4AnaCOfkAArF04lTrf4TU0Zl-sxYF4fWh6dqUxDJlzLS9eX16GbaJ4i_XeiMD1JaeIAAVMVgLKg2pxI1IOIqGqPnXpdrq4GM_dX4wRry7oOIEjju_bWDU8_SA0VlQ4RIHmCYpYS2BE1HUI-I3CA8h2XGGc0AnpFASInvEfohNj41r4OMUOMg4J-Y0yMio8L9PcmFeYbwz4gXI-fCp-XEhHOIMpnUvfgaSNV8vSkBFBzkDLVH9tNWZNlIa88i8z0lOPnXbUuWkE6DPHrWNlZj2ui2HyhDWydOukNTZd1g6dsq7lz1Z_L3_tbb3ffbLVf7W9873bX_6Sr2_ubL9wemufe6ubefdR_9Ob3Yfd3saP3reX_deP818_-x_X8vXV_OlG_nyl3_2Qr7wFnNPWTCucaUzVynfJ1BKIMGqZFzvK9vyEQz4IOarwYi_JvCxpRyn4I8ncthCx68eOm6b4SgoXDNPmPMqkylLI2s5Yo507neysNS7sVDlxysGOjpd4iRQq890YID-zZSbPWROlHebKqeLe3D796fzB0C5YR4v9a1z0vWiNzt9dyC5BGjQfX6aO-Afp2P0-
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%8D%8A%E8%83%B1%E6%B0%A8%E9%85%B0%E7%99%BD%E4%B8%89%E7%83%AF%E5%8F%97%E4%BD%932%E6%8B%AE%E6%8A%97%E5%89%82%E7%AD%9B%E9%80%89%E6%96%B9%E6%B3%95%E7%9A%84%E5%BB%BA%E7%AB%8B%E5%8F%8A%E5%8C%96%E5%90%88%E7%89%A9%E5%88%9D%E7%AD%9B&rft.jtitle=%E6%B5%99%E6%B1%9F%E5%A4%A7%E5%AD%A6%E5%AD%A6%E6%8A%A5%EF%BC%88%E5%8C%BB%E5%AD%A6%E7%89%88%EF%BC%89&rft.au=%E8%94%A1%E8%93%93%E8%95%BE&rft.au=%E9%BB%84%E9%9B%AA%E7%90%B4&rft.au=%E8%91%A3%E6%99%93%E6%AD%A6&rft.au=%E6%96%B9%E4%B8%89%E5%8D%8E&rft.date=2009&rft.pub=%E6%B5%99%E6%B1%9F%E5%A4%A7%E5%AD%A6%E5%8C%BB%E5%AD%A6%E9%99%A2%E8%8D%AF%E7%90%86%E5%AD%A6%E7%B3%BB%2C%E6%B5%99%E6%B1%9F%2C%E6%9D%AD%E5%B7%9E%2C310058%25%E6%B5%99%E6%B1%9F%E5%A4%A7%E5%AD%A6%E8%8D%AF%E5%AD%A6%E9%99%A2%E8%8D%AF%E7%89%A9%E7%A0%94%E7%A9%B6%E6%89%80%2C%E6%B5%99%E6%B1%9F%2C%E6%9D%AD%E5%B7%9E%2C310058&rft.issn=1008-9292&rft.volume=38&rft.issue=6&rft.spage=598&rft.epage=604&rft_id=info:doi/10.3785%2Fj.issn.1008-9292.2009.06.008&rft.externalDocID=zjdxxb_yxb200906008
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzjdxxb-yxb%2Fzjdxxb-yxb.jpg